approval · primary record
ORITAVANCIN DIPHOSPHATE
FDA · NDA · 2025-04-24
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-04-24 |
| Brand | KIMYRSA |
| Sponsor | MELINTA THERAP |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T03:30:03.002Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:ORITAVANCIN DIPHOSPHATE:2025-04-24
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.